Research suggests a reduced expression of FOXP3 (a transcriptional regulatory factor) in peripheral CD4CD25 Tregs of AAA patients, leading to functional deficiencies in overall CD4CD25 Tregs, indicating impaired immune regulation by Tregs, which may contribute to the disease progression of AAA (35). The gene discussed is FOXP3; the disease is triple-A syndrome.